Ritika Bakhru, MD
NPI 1972765139 · Ophthalmology Physician · Hillsborough, NJ
Enrolled with Medicare as Practitioner - Ophthalmology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Ritika Bakhru, MD is a Ophthalmology Physician provider in Hillsborough, NJ (NPI 1972765139).
Provider details
- NPI number
- 1972765139
- Entity type
- Individual
- Primary specialty
- Ophthalmology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Female
- Sole proprietor
- No
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Student, Health Care
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
17 yrs in NPPES registry
- Profile completeness25% of score
83% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,649 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Complete Exam of Visual System92014 | 602 | $140 |
| Established Patient Problem Focused Exam of Visual System92012 | 288 | $99 |
| Photography of the Retina92250 | 244 | $41 |
| Imaging of Optic Nerve92133 | 137 | $40 |
| Imaging of Retina92134 | 112 | $45 |
| New Patient Complete Exam of Visual System92004 | 108 | $164 |
| Exam of Visual Field With Extended Testing92083 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 14 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Latanoprost | 203 | 63 |
| Prednisolone Acetate | 68 | 55 |
| Timolol Maleate | 57 | 17 |
| Neomycin/Polymyxin B/Dexamethabrand: Neomycin-Polymyxin-Dexameth | 56 | 49 |
| Dorzolamide Hcl/Timolol Maleatbrand: Dorzolamide-Timolol | 55 | 18 |
| Brimonidine Tartrate | 40 | 17 |
| Brimonidine Tartrate/Timololbrand: Combigan | 21 | — |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$233 across 13 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2008-06-30
- Last updated
- 2017-07-05
Frequently asked questions
- What is Ritika Bakhru's NPI number?
- Ritika Bakhru's National Provider Identifier (NPI) is 1972765139, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Ritika Bakhru's specialty?
- Ritika Bakhru is listed in the NPPES registry with a primary specialty of Ophthalmology Physician (Allopathic & Osteopathic Physicians).
- Where is Ritika Bakhru located?
- Ritika Bakhru's practice location on file with NPPES is 25 Steeple Dr, Hillsborough, NJ 08844-2920.
- What is Ritika Bakhru's phone number?
- The practice phone number listed in the NPPES registry for Ritika Bakhru is (908) 359-4285.
- Does Ritika Bakhru accept Medicare?
- Ritika Bakhru is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Ritika Bakhru's NPI active?
- Yes — Ritika Bakhru's NPI (1972765139) is active in the NPPES registry as of the last update on 2017-07-05.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.